U.S. FDA places clinical hold on Neumora's schizophrenia drug study

Neumora Therapeutics

15/04/2024 11:36

April 15 (Reuters) - Neumora Therapeutics  NMRA.O  said
on Monday the U.S. Food and Drug Administration had placed a
clinical hold on early-stage study of its experimental
schizophrenia drug. 

 (Reporting by Sneha S K in Bengaluru; Editing by Shinjini
Ganguli)
 ((Sneha.SK@thomsonreuters.com;))